The Asia Pacific Digital Health For Cardiovascular Market is expected to witness market growth of 22.6% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Digital Health For Cardiovascular Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $12.25 billion by 2031. The Japan market is registering a CAGR of 21.9% during 2024-2031. Additionally, the India market is expected to showcase a CAGR of 23.5% during 2024-2031.
Government initiatives and regulatory support have further fueled the growth of the digital health for cardiovascular market. The U.S. Food and Drug Administration (FDA) has fostered innovation in the United States by establishing clear regulatory pathways for digital health products. The FDA's Digital Health Innovation Action Plan, which was implemented in 2017, established the foundation for the efficient review and certification of digital health technologies, such as wearable devices, software as a medical device (SaMD), and mobile medical apps.
The European Medicines Agency (EMA) and the European Commission (EC) have collaborated to establish a regulatory environment that is conducive to digital health innovations in Europe. The rules governing the safety and performance of medical devices, including digital health technologies and software used in cardiovascular care, were strengthened by the Medical Device Regulation (MDR), which was implemented in May 2021.
As numerous countries in the Asia-Pacific region undergo rapid economic expansion, there has been a substantial change in dietary habits, with a rise in the consumption of ultra-processed foods that are frequently high in sugar, saturated fats, and sodium. This transition has contributed to a sharp rise in obesity, hypertension, and diabetes, all of which are major risk factors for cardiovascular diseases (CVD). Consequently, CVD has emerged as one of the leading causes of death across the region, driving the urgent need for advanced digital health solutions to support early detection, prevention, and effective management of cardiovascular conditions. According to the World Health Organization (WHO), in the South-East Asia Region, 3.6 million lives are lost every year due to cardiovascular diseases. In response, the WHO launched SEA HEARTS, the "WHO South-East Asia HEARTS initiative," to scale up and integrate ongoing initiatives aimed at reducing deaths from CVD by one-third by 2030 in this region. Similarly, in Australia, cardiovascular disease continues to be a significant health challenge.
The China market dominated the Asia Pacific Digital Health For Cardiovascular Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $12.25 billion by 2031. The Japan market is registering a CAGR of 21.9% during 2024-2031. Additionally, the India market is expected to showcase a CAGR of 23.5% during 2024-2031.
Government initiatives and regulatory support have further fueled the growth of the digital health for cardiovascular market. The U.S. Food and Drug Administration (FDA) has fostered innovation in the United States by establishing clear regulatory pathways for digital health products. The FDA's Digital Health Innovation Action Plan, which was implemented in 2017, established the foundation for the efficient review and certification of digital health technologies, such as wearable devices, software as a medical device (SaMD), and mobile medical apps.
The European Medicines Agency (EMA) and the European Commission (EC) have collaborated to establish a regulatory environment that is conducive to digital health innovations in Europe. The rules governing the safety and performance of medical devices, including digital health technologies and software used in cardiovascular care, were strengthened by the Medical Device Regulation (MDR), which was implemented in May 2021.
As numerous countries in the Asia-Pacific region undergo rapid economic expansion, there has been a substantial change in dietary habits, with a rise in the consumption of ultra-processed foods that are frequently high in sugar, saturated fats, and sodium. This transition has contributed to a sharp rise in obesity, hypertension, and diabetes, all of which are major risk factors for cardiovascular diseases (CVD). Consequently, CVD has emerged as one of the leading causes of death across the region, driving the urgent need for advanced digital health solutions to support early detection, prevention, and effective management of cardiovascular conditions. According to the World Health Organization (WHO), in the South-East Asia Region, 3.6 million lives are lost every year due to cardiovascular diseases. In response, the WHO launched SEA HEARTS, the "WHO South-East Asia HEARTS initiative," to scale up and integrate ongoing initiatives aimed at reducing deaths from CVD by one-third by 2030 in this region. Similarly, in Australia, cardiovascular disease continues to be a significant health challenge.
List of Key Companies Profiled
- Apple, Inc.
- Orange S.A.
- Epic Systems Corporation
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- CardiAI.Inc
- Vista.ai (HeartVista, Inc.)
- Viz.ai, Inc.
- Cleerly, Inc.
- RSIP Vision Ltd.
Market Report Segmentation
By Component
- Services
- Software
- Hardware
By End-use
- Patients
- Providers
- Payers
- Other End-use
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Asia Pacific Digital Health For Cardiovascular Market by Component
Chapter 6. Asia Pacific Digital Health For Cardiovascular Market by End-use
Chapter 7. Asia Pacific Digital Health For Cardiovascular Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Apple, Inc.
- Orange S.A.
- Epic Systems Corporation
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- CardiAI.Inc
- Vista.ai (HeartVista, Inc.)
- Viz.ai, Inc.
- Cleerly, Inc.
- RSIP Vision Ltd.
Methodology
LOADING...
